December 19, 2014 11:41 PM ET

Biotechnology

Company Overview of Trellis Bioscience, Inc.

Company Overview

Trellis Bioscience, Inc. discovers and develops human antibody therapeutics for infectious disease and oncology indications. It provides CellSpot, a technology to find antibodies from human blood cells. The company was founded in 1998 and is based in South San Francisco, California.

2 Corporate Drive

South San Francisco, CA 94080

United States

Founded in 1998

Phone:

650-616-1100

Fax:

650-589-4860

Key Executives for Trellis Bioscience, Inc.

Chief Executive Officer and President
Age: 54
Executive Chairman
Age: 60
Co-Founder and Science Advisor
Chief Medical Officer
Compensation as of Fiscal Year 2014.

Trellis Bioscience, Inc. Key Developments

Trellis Bioscience Appoints Michael Greenberg as VP of Business Development

Trellis Bioscience announced that Michael Greenberg joining the company as VP of Business Development. Michael Greenberg comes to Trellis after spending twenty years specializing in international alliance negotiation, and cross-national alliance management. From 2000-2103, Michael was based at MPM Capital in Boston, San Francisco, and Tokyo working as Vice President, Business Development and other long term and interim positions for more than one dozen portfolio companies including Cerimon, Kourion, Radius Health, Sai Advantium, and Dragonfly Sciences.

Amorfix Life Sciences and Trellis Bioscience to Collaborate on Anti-CD38 Antibody Treatment for Cancer

Amorfix Life Sciences announced that it has entered into a collaboration with Trellis Bioscience to develop antibodies against misfolded CD38 protein as a treatment for haematological malignancies including leukemia and lymphoma. Trellis's discovery platform, called CellSpot(TM), uses computerized microscopy to drastically miniaturize a multiplexed antigen binding assay capable of characterizing millions of individual antibody producing B cells. Hence, CellSpot enables discovery of very rare high quality human antibodies usually not detectable with standard techniques. Amorfix's ProMIS(TM) Discovery technology identifies disease specific epitopes (DSE's) that are present only on diseased cells. Together, the complementary technologies will enable the companies to isolate and develop fully human therapeutic antibodies that will target only cancer cells and not healthy ones. Under the terms of the collaboration, Amorfix will have an exclusive option to develop any resulting antibodies.

Trellis Bioscience to Collaborate on Anti CD38 Antibody Treatment for Cancer

Amorfix Life Sciences announced that it has entered into a collaboration with Trellis Bioscience to develop antibodies against misfolded CD38 protein as a treatment for haematological malignancies including leukemia and lymphoma. Trellis is a private, South San Francisco-based therapeutic antibody company formed around a breakthrough discovery platform capable of isolating therapeutic grade antibodies directly from the blood cells of humans. The Company's discovery platform, called CellSpotTM, uses computerized microscopy to drastically miniaturize a multiplexed antigen binding assay capable of characterizing millions of individual antibody producing B cells. Hence, CellSpot enables discovery of very rare high quality human antibodies usually not detectable with standard techniques. Amorfix's ProMIS(TM) Discovery technology identifies disease specific epitopes (DSE's) that are present only on diseased cells. Together, the complementary technologies will enable the companies to isolate and develop fully human therapeutic antibodies that will target only cancer cells and not healthy ones. Under the terms of the collaboration, Amorfix will have an exclusive option to develop any resulting antibodies.

Similar Private Companies By Industry

Company Name Region
Crescendo Pharmaceuticals Corporation United States
Modular Genetics, Inc. United States
Tendyne Medical, Inc. United States
Tyrogenix United States
Micell Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Trellis Bioscience, Inc., please visit www.trellisbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.